Topical Ketoconazole for Pattern Hair Loss: Fields 2020 Research Summary

Last verified: Apr 2026Ketoconazole ShampooVery limited evidence

This is a plain-language summary of the original published research. We do not add conclusions or opinions of our own. This is not medical advice — consult a certified healthcare practitioner before making any decision.

Original research published in Dermatologic Therapy, 2020

Topical Ketoconazole for Pattern Hair Loss: Fields 2020 Research Summary

Read original →

Study conclusion

This systematic review found that topical ketoconazole (an antifungal shampoo) showed positive effects on hair shaft diameter and photographic assessments of hair loss across 5 human studies. However, no placebo-controlled randomised controlled trial of ketoconazole as a standalone hair loss treatment exists. The evidence is limited and requires better-designed studies to confirm.

Strength of evidence

Strength of evidence
Very limited evidence · 4/10

Who it applies to

Who was studied

Adults with pattern hair loss. 318 human participants across 5 studies. Topical ketoconazole 1% or 2% shampoo applied to the scalp.

Who was NOT studied

People with hair loss types other than pattern hair loss. People with scalp conditions that might independently affect hair growth.

What to look for when shopping

Ketoconazole 1% shampoo is available over the counter. Ketoconazole 2% requires a prescription. Neither is FDA-approved for hair loss — only for dandruff and scalp conditions. The evidence for hair loss is limited and no placebo-controlled RCT exists.

What research cannot help you decide

Whether ketoconazole will produce meaningful hair regrowth for you. How it compares to minoxidil or other established treatments. What the optimal concentration or frequency of use is.

Key findings

  • All 5 human studies reported increased hair shaft diameter after ketoconazole use
  • Photographic assessment showed clinical improvement in the included studies
  • One small study found ketoconazole produced similar improvements to 2% minoxidil — but this study had significant design limitations
  • No placebo-controlled randomised controlled trial of ketoconazole for hair loss exists
  • Ketoconazole is not FDA-approved for hair loss

What this study does not show

  1. 1.Whether ketoconazole produces meaningful hair regrowth compared to placebo. No adequately designed placebo-controlled RCT exists.
  2. 2.What the optimal concentration (1% vs 2%) or frequency of use is.
  3. 3.Whether ketoconazole works better as a standalone treatment or adjunct to minoxidil or finasteride.
  4. 4.Whether it works for hair loss types other than pattern hair loss.

Limitations

  1. 1.No placebo-controlled randomised controlled trial of ketoconazole as a standalone hair loss treatment exists.
  2. 2.Only 5 human studies were included — a very thin evidence base.
  3. 3.Total human sample size was 318 across all studies.
  4. 4.The foundational RCT (Pierard-Franchimont 1998) was small and has never been replicated with adequate controls.
  5. 5.Mechanism of action in hair loss is not fully established.

Used in these articles

Links added as fact-checks and articles citing this study are published.